Strategic advisory ECG is a boutique biotechnology consulting firm with a track record of supporting medical products development and commercialization for both large multinationals and small entrepreneurial companies, signaling opportunities to offer end-to-end product lifecycle services.

Long-term relationships With over 85 percent of clients retained long term, there is a foundation for upsell and cross-sell into existing accounts, especially as clients scale or pivot to new products or indications.

Industry expertise Specialized focus on the medical products industry positions ECG to provide differentiated solutions for regulatory strategy, market access, and cross-functional program management, which can be packaged into repeatable service offerings.

Growth-ready platforms Smaller firm size and revenue under one million indicate potential for scalable, high-margin consulting engagements, digital transformation initiatives, and standardized methodologies that appeal to mid-market clients seeking cost-effective expertise.

Tech-enabled delivery Utilizing cloud-based tools and modern tech stack suggests opportunities to offer data-driven,accelerated project delivery, remote collaboration workflows, and managed services for global product programs.